A prospective, blinded study of a PF4-dependent assay for HIT diagnosis (original) (raw)
The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
Vishal Jindal
Cureus, 2018
View PDFchevron_right
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
Vishal Jindal
Journal of Blood Medicine, 2020
View PDFchevron_right
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis
B. Chong
Journal of Thrombosis and Haemostasis, 2011
View PDFchevron_right
PIFA PLUSS P4 Assay for Screening of Heparin-Induced Thrombocytopenia
nt nghia
Laboratory medicine, 2018
View PDFchevron_right
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
angela rogolino
Journal of Clinical Medicine, 2020
View PDFchevron_right
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia
GUALTIERO PALARETI
Thrombosis and haemostasis, 2010
View PDFchevron_right
Evaluating Heparin-Induced Thrombocytopenia: The Old and the New
M. Morel-Kopp
Seminars in Thrombosis and Hemostasis, 2012
View PDFchevron_right
False-Negative Platelet Factor 4 Antibodies and Serotonin Release Assay and the Utility of Repeat Testing in the Diagnosis of Heparin-Induced Thrombocytopenia and Thrombosis
Pravin George
Case Reports in Hematology, 2019
View PDFchevron_right
Prevalence, isotype, and functionality of antiheparin–platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia
Sarfraz Ahmad
Thrombosis Research, 2002
View PDFchevron_right
Decision Analysis for Use of Platelet Aggregation Test, Carbon 14–Serotonin Release Assay, and Heparin–Platelet Factor 4 Enzyme-Linked Immunosorbent Assay for Diagnosis of Heparin-lnduced Thrombocytopenia
J. Amiral
American Journal of Clinical Pathology, 1999
View PDFchevron_right
Timely diagnosis and management of heparin‐induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassay
Steven Austin
British Journal of Haematology, 2008
View PDFchevron_right
Contributions of biological tests and the 4 Ts score in the diagnosis of heparin induced thrombocytopenia
BRAHIM ADMOU
2012
View PDFchevron_right
Pathogenic heparin‐induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry
Varda Deutsch
European Journal of Haematology, 2019
View PDFchevron_right
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia
Jean AMIRAL
American journal of clinical pathology, 1999
View PDFchevron_right
Heparin‐Induced Thrombocytopenia: Pathophysiology, Diagnosis, and Treatment Monitoring
Dimitrios Stylos
Drug Development Research, 2013
View PDFchevron_right
Heparin-induced thrombocytopenia: natural history, diagnosis, and management
Teresa Carman
Vascular Medicine, 2001
View PDFchevron_right
Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia
Eleanor Pollak
Seminars in thoracic and cardiovascular surgery, 2005
View PDFchevron_right
Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia
Marco Vitale
Cytometry, 2001
View PDFchevron_right
Use of a whole‐cell ELISA to detect additional antibodies in setting of suspected heparin‐induced thrombocytopenia
Robert W. Maitta
European Journal of Haematology, 2019
View PDFchevron_right
Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay
Jean AMIRAL
Transfusion, 1994
View PDFchevron_right
Thrombosis in Suspected Heparin-Induced Thrombocytopenia Occurs More Often With High Antibody Levels
John Fanikos
American Journal of Medicine
View PDFchevron_right
Heparin-Induced Thrombocytopenia (HIT)
Tomislav Vuk
Anticoagulant Drugs, 2018
View PDFchevron_right
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells
john paul
Journal of Clinical Investigation, 1994
View PDFchevron_right
Clinical Outcomes in a Cohort of Patients with Heparin-induced Thrombocytopenia
Nigel Key
American journal of hematology, 2017
View PDFchevron_right
Improved laboratory confirmation of heparin-induced thrombocytopenia type II. Time course of antibodies and combination of antigen and biologic assays
Job Harenberg
American journal of clinical pathology, 2001
View PDFchevron_right
Obstacles in the diagnostics and therapy of heparin-induced thrombocytopenia
Slobodan Obradovic
Srpski arhiv za celokupno lekarstvo, 2010
View PDFchevron_right
Heparin-induced thrombocytopenia: principles for early recognition and management
Amjad Almahameed
Cleveland Clinic Journal of Medicine, 2005
View PDFchevron_right
The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia
Clifford Takemoto
Clinical and Applied Thrombosis/Hemostasis
View PDFchevron_right
Update on Mechanisms, Pathogenicity, Heterogeneity of Presentation, and Laboratory Diagnosis of Heparin-Induced Thrombocytopenia
Jean AMIRAL
Anticoagulation drugs - the Current State of the Art [Working Title]
View PDFchevron_right
Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT)
Sentot Santoso
Thrombosis Research, 2011
View PDFchevron_right